U.S. Representative Larry Bucshon, M.D. (R-IN-08) released the following statement after joining U.S. Representative Greg Murphy, M.D. (R-NC-03) and other bipartisan cosponsors in introducing the Medicare Patient Access and Practice Stabilization Act to support physicians and protect access to care for Medicare beneficiaries earlier this week:
"All patients deserve timely access to… Read more »
Washington, D.C. – U.S. Representatives Larry Bucshon, M.D. (R-IN), Mike Kelly (R-PA), Suzan DelBene (D-WA), Ami Bera, M.D. (D-CA), and U.S. Senators Roger Marshall, M.D. (R-KS), Kyrsten Sinema (I-AZ), John Thune (R-SD), and Sherrod Brown (D-OH) reintroduced the Improving Seniors’ Timely Access to Care Act. The bipartisan, bicameral legislation streamlines the prior authorization process… Read more »
WASHINGTON, D.C. — Today, Congressman Larry Bucshon, M.D. (IN-08) and Congresswoman Diana DeGette (CO-01) sent a letter to stakeholders, interest groups, and health care advocates requesting information on what Congress can do to bring about the next generation of treatments.
“The 21st Century Cures Act has been tremendously successful in accelerating… Read more »
WASHINGTON – Today, U.S. Representatives Larry Bucshon, MD (R-IN-08), Buddy Carter (R-GA-01), and Diana Harshbarger (R-TN-01) introduced the 340B Affording Care for Communities and Ensuring a Strong Safety-Net Act (340B ACCESS Act). This legislation establishes critical oversight and transparency of the 340B program - while providing clear, practical,… Read more »
WASHINGTON – On Wednesday, Congressman Larry Bucshon, M.D. (R-IN-08) and Congressman Raul Ruiz, M.D. (D-CA-25) introduced bipartisan legislation (H.R. 8412) to improve participation in clinical trials by underrepresented populations.
The Clinical Trial Modernization Act builds on the successes of clinical trials legislation passed into law last Congress by addressing economic… Read more »
WASHINGTON D.C. — Today, Congressman Larry Bucshon, M.D. (IN-08) and Congresswoman Diana DeGette (CO-01) released the following statement after the Food and Drug Administration (FDA) finalized a rule regulating lab-developed tests (LDTs), a subset of in-vitro clinical tests (IVCTs).
“Rational oversight of in-vitro diagnostics, including laboratory-developed tests, is vital for innovation… Read more »
WASHINGTON – Today, U.S. Representative Larry Bucshon, M.D. (R-IN-08) joined a bipartisan group of Members of Congress to introduce the Supplemental Oxygen Access Reform (SOAR) Act. The legislation makes critical reforms to improve access to supplemental oxygen for Medicare beneficiaries. Dr. Bucshon was joined in introduction by Reps. David Valadao (CA-22), Julia… Read more »
WASHINGTON – Today, the U.S. House Energy and Commerce Subcommittee on Health held a hearing focused on evaluating approaches to diagnostic test regulation. U.S. Representative Larry Bucshon, M.D. (R-IN-08), Vice Chair of the Health Subcommittee, has been a leading voice calling for the creation of a new framework to verify the accuracy of various medical tests… Read more »
WASHINGTON – Today, U.S. Representative Larry Bucshon, M.D. (R-IN-08) voted to pass the Dr. Michael C. Burgess Preventive Health Savings Act (H.R. 766) to amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Dr. Bucshon spoke in favor of the Dr. Michael C. Burgess Preventive Health… Read more »
WASHINGTON – U.S. Representatives Larry Bucshon, M.D. (R-IN-08), and Ami Bera, M.D. (D-CA-06) on March 6, 2024, penned a letter to U.S. Department of Health and Human Services Secretary Becerra regarding the recent cybersecurity attack on Change Healthcare. The substance of their request—that the agency work to protect all types of providers… Read more »
